Reversible cerebellar syndrome caused by metronidazole
Authors:
- A. Keith W. BrownellABA. Keith W. Brownell
- Sarah FurtadoSFSarah Furtado
- 14 September 2009
- journal article
- case report
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 181 (9) , 611-613
Abstract
A 54-year-old man presented with a 3-day history of difficulty speaking and an unsteady gait after having a generalized tonic-clonic seizure. He had been taking oral metronidazole for bronchiectasis for 2 months before presentation (estimated cumulative dose of about 60 g). His medical historyKeywords
This publication has 10 references indexed in Scilit:
- Lésions cérébelleuses réversibles et neuropathie périphérique induites par le métronidazoleMedecine Et Maladies Infectieuses, 2009
- Cerebellar ataxia following prolonged use of metronidazole: case report and literature reviewInternational Journal of Infectious Diseases, 2008
- MR Imaging of Metronidazole-Induced Encephalopathy: Lesion Distribution and Diffusion-Weighted Imaging FindingsAmerican Journal of Neuroradiology, 2007
- Reversible optic neuropathy due to metronidazoleClinical & Experimental Ophthalmology, 2007
- Metronidazole: Newly Recognized Cause of Autonomic NeuropathyJournal of Child Neurology, 2006
- Metronidazole-Induced Encephalopathy and Inferior Olivary HypertrophyArchives of Neurology, 2003
- Reversible Metronidazole-Induced Lesions of the Cerebellar Dentate NucleiNew England Journal of Medicine, 2002
- Evaluation of metronidazole toxicity: a prospective study.1999
- Central Nervous System Toxicity Associated with Metronidazole TherapyAnnals of Internal Medicine, 1980
- Neurologic Toxicity Associated with High-Dose Metronidazole TherapyAnnals of Internal Medicine, 1978